EXCHANGE AGREEMENTExchange Agreement • April 13th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionJeff Eliot Margolis (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on April 12, 2023, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series J 8% Voting, Participating, Redeemable Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AND SETTLEMENT AGREEMENTExchange and Settlement Agreement • April 13th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionMarc M Radin PC (the “Vendor”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on April 12, 2023, whereby Vendor will exchange and settle certain accounts payable and other liabilities owed to the Vendor by the Company for shares of Series J 8% Voting, Participating, Redeemable Preferred Stock, par value $0.001, stated value $100.00 (the “Preferred Stock”), of the Company (the “Exchange and Settlement”).
EXCHANGE AND SETTLEMENT AGREEMENTExchange and Settlement Agreement • April 13th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionArnold S. Lippa (the “Executive”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on April 12, 2023, whereby Executive will exchange and settle certain liabilities, debt and compensation owed to the Executive by the Company for shares of Series J % Voting, Participating, Redeemable Preferred Stock, par value $0.001, stated value $100.00 (the “Preferred Stock”), of the Company (the “Exchange and Settlement”).